top biopharmaceuticals for glp-1 medication Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch 3 Companies at the Forefront

Other GLP-1 Pills in the Pipeline Although Wegovy is the first GLP-1 pill the FDA has approved for weight management, drug manufacturers are funding trials for additional oral GLP-1 medications

Higher obesity rates and a continually rising diabetes burden are generating meaningful demand for advanced care solutions

We anticipate around seven actual launches in the US by 2030 after risk-adjustment

orforglipron This small-molecule drug likely won't require the strict 30-minute fasting rule because the stomach does not break it down as easily

An effective oral GLP-1 could challenge the current injectable market leaders and avoid supply chain issues

In 2023, Pfizer announced a 500% price increase for the Comirnaty